3,4-Dimethoxybenzyl alcohol

CAS No. 93-03-8

3,4-Dimethoxybenzyl alcohol( —— )

Catalog No. M16658 CAS No. 93-03-8

3,4-Dimethoxybenzyl Alcohol is an organic compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 38 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,4-Dimethoxybenzyl alcohol
  • Note
    Research use only, not for human use.
  • Brief Description
    3,4-Dimethoxybenzyl Alcohol is an organic compound.
  • Description
    3,4-Dimethoxybenzyl Alcohol is an organic compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    93-03-8
  • Formula Weight
    168.19
  • Molecular Formula
    C9H12O3
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    COC1=C(OC)C=C(CO)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tien M, et al. J Biol Chem. 1986 Feb 5;261(4):1687-93.
molnova catalog
related products
  • Phospho(enol)pyruvic...

    Phosphoenolpyruvic acid monopotassium salt is involved in glycolysis and gluconeogeneis. In glycolysis PEP is metabolized by Pyruvate Kinase to yield pyruvate. In plants PEP is involved in the formation of aromatic amino acids as well as in the carbon fixation pathway.

  • Methyl retinoate

    Methyl retinoate (Retinoic acid, methyl ester) induces aseptic inflammation at the site of administration in in vivo experiments, which causes an increase in the number of leukocytes in the blood and a decrease in the levels of red blood cells and Hb.Methyl retinoate promotes spontaneous leukemia.Methyl retinoate can be Used in the treatment of gastric hypertrophy and ulcers due to vitamin A deficiency.

  • Ethyl oleate

    Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?